Triple Regulator (RT)
LY3437943 Research Compound
Triple agonist GLP-1/GIP/glucagon receptor peptide for research applications.
GLP-1, also known as LY3437943, is an investigational triple hormone receptor agonist studied for its activity at the GIP, GLP-1, and glucagon receptors. Scientific research has evaluated GLP-1 in clinical and metabolic research settings related to receptor signaling, glucose-dependent insulinotropic polypeptide pathways, glucagon-like peptide-1 pathways, glucagon receptor activity, metabolic regulation, and metabolic-research models.
Available Format
Click option to switch formatProduct Overview
GLP-1 is an investigational peptide compound being studied for its activity across three receptor systems: GIP, GLP-1, and glucagon. These receptor pathways are involved in metabolic signaling, energy-balance research, glucose-related pathways, and metabolic-regulation models. GLP-1 is not FDA-approved for commercial use, medical use, personal use, or treatment use. It is still under clinical investigation, with ongoing trials evaluating safety and efficacy in metabolic-research participants. This product is not presented as a medication, supplement, weight-loss product, or treatment. It is supplied strictly for qualified laboratory research-use only.
Selected Price Option
Select Delivery Terms
Strictly for laboratory research use only. Not for human or animal consumption.
Research Pathways & Mechanisms
Triple-Receptor Signaling Research
GLP-1 is studied in triple-receptor metabolic signaling research.
GLP-1 Pathway Research
GLP-1 has been studied in GLP-1 receptor pathway models.
GIP Pathway Research
GLP-1 has been studied in GIP receptor signaling and nutrient-response research.
Glucagon Receptor Research
GLP-1 has been studied in glucagon receptor and energy-balance research models.
Metabolic & Energy-Balance Research Models
GLP-1 has been evaluated in published clinical literature for metabolic endpoints; this material is supplied only for qualified in-vitro laboratory research and is not for clinical use.
Composition & Technical Specifications
Regulatory Disclaimer
The products available on this site are intended solely for in vitro laboratory research purposes and are not for human or animal consumption, diagnostic, therapeutic, or clinical use. Purchasers must be qualified research professionals. All buyers assume full responsibility for compliance with all applicable local, state, and federal regulations regarding the handling, storage, and use of these research compounds.
Handling, Storage & Research Compliance Protocols
Storage Instructions
Store lyophilized powder at -20°C. Protect from light and moisture. Preparation, aliquoting, and post-preparation storage must follow the purchaser’s validated laboratory SOPs and batch-specific documentation. Pretty Peptide Collective does not provide human-use dosing, injection, or administration guidance. Handle with appropriate personal protective equipment (PPE) in a controlled environment.
Research Constraints & Regulatory Disclaimers
- ✕ Not a medication or compounded drug
- ✕ Not a prescription product
- ✕ Not a weight-loss product
- ✕ Not a GLP-1 treatment
- ✕ Not a supplement or wellness product
- ✕ Not an alternative to Ozempic/Mounjaro
- ✕ Strictly for laboratory research